Recombinant Human Anti-C. difficile TcdB Antibody (PA41) (CAT#: PABC-308)

This product is a recombinant Human antibody that can recognize C. difficile TcdB. PA41, a humanized monoclonal antibody capable of neutralizing TcdB from a diverse array of C. difficile strains.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
Inhib

Figure 1 PA41 inhibits TcdB-induced Rac1 glucosylation in Caco-2 cells but not <em>in vitro</em>.

Figure 1 PA41 inhibits TcdB-induced Rac1 glucosylation in Caco-2 cells but not in vitro.

A, in vitro glucosylation of GST-Rac1 (2 μM) by TcdB-027-GTD (10 nM) in the presence of [¹⁴C]UDP-glucose (24 μM) and increasing concentrations of PA41 mAb. Controls are shown in lane 1 (GTD with Rac1) and lane 2 (Rac1 only). B, Rac1 glucosylation by TcdB(WT) or TcdB(Y323H) in the presence of isotype control or PA41 mAb was assessed in Caco-2 cells. Cells that did not receive toxin or antibody were used as controls. C, experiments in B were quantified by densitometry, and the extent of Rac1 glucosylation was determined by normalizing the unglucosylated and total Rac1 levels. Means ± S.D. (n = 3) are shown. D and E, similar experiment performed with Fab fragments. The antibody concentration was doubled to keep the available number of antigen-binding sites similar between the mAb and Fab experiments. Error bars represent S.D.

Kroh, H. K., Chandrasekaran, R., Zhang, Z., Rosenthal, K., Woods, R., Jin, X., ... & Spiller, B. W. (2018). A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells. Journal of Biological Chemistry, 293(3), 941-952.

Inhib

Figure 2 PA41 inhibits pore formation and the subsequent delivery of the GTD into the cytosol.

Figure 2 PA41 inhibits pore formation and the subsequent delivery of the GTD into the cytosol.

A, pore formation on biological membranes. TcdB holotoxin alone (1 nM) or preincubated with PA41 mAb or Fab (10 nM) was applied to CHO-K1 cells preloaded with 86Rb+, and rubidium release was compared at pH 7.5 and 4.5. Means ± S.D. (n = 6) are shown. B, Caco-2 monolayers were intoxicated with 3xFLAG-TcdB (25 nM) preincubated with equimolar (25 nM) amounts of control or PA41 mAb. Toxin cleavage assays were performed as described under "Experimental procedures." Blots were probed with antibodies against the toxin (anti-FLAG; detects both internalized holotoxin and free GTD), unglucosylated and total Rac1, and GAPDH. C, the fraction of the internalized toxin that is cleaved and released in each condition was determined by normalizing the free GTD signal to the corresponding internalized holotoxin signal. For each time point, the fractional GTD release measurements were normalized to that of the isotype mAb controls to obtain the relative GTD cleavage. D and E, similar experiments performed with the Fab fragments. Means ± S.D. (n = 3) are shown. Error bars represent S.D.

Kroh, H. K., Chandrasekaran, R., Zhang, Z., Rosenthal, K., Woods, R., Jin, X., ... & Spiller, B. W. (2018). A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells. Journal of Biological Chemistry, 293(3), 941-952.


Specifications

  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • Human IgG
  • Specificity
  • C. difficile TcdB
  • Species Reactivity
  • C. difficile
  • Clone
  • PA41
  • Applications
  • ELISA, Inhib

Product Property

  • Purity
  • >95% as determined by analysis by SDS-PAGE
  • Storage
  • Store at -20°C for long-term storage. Avoid freeze/thaw cycles.

Applications

  • Application Notes
  • The antibody PA41 has been reported in applications of Enzyme-linked Immunosorbent Assay, Inhibition. It's recommended that the optimal antibody concentration, dilution, incubition time etc. be carefully titrated in specific assays.

Target

  • Alternative Names
  • C. difficile TcdB; Clostridium difficile TcdB

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone PA41"

See other products for "C. difficile TcdB"

Fab Fragment Antibody

CAT Product Name Application Type
PFBC-308 Recombinant Human Anti-C. difficile TcdB Antibody Fab Fragment (PA41) ELISA, Neut Human Fab

scFv Fragment Antibody

CAT Product Name Application Type
PSBC-308 Recombinant Human Anti-C. difficile TcdB Antibody scFv Fragment (PA41) ELISA, Neut Human scFv

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for PABC-308. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare